ID: ALA358074

Max Phase: Preclinical

Molecular Formula: C21H16O3

Molecular Weight: 316.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C(=C/c1ccccc1)c1ccc(O)cc1)c1ccc(O)cc1

Standard InChI:  InChI=1S/C21H16O3/c22-18-10-6-16(7-11-18)20(14-15-4-2-1-3-5-15)21(24)17-8-12-19(23)13-9-17/h1-14,22-23H/b20-14+

Standard InChI Key:  KBIROZFRRGUECR-XSFVSMFZSA-N

Associated Targets(non-human)

Estrogen receptor beta 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Estrogen receptor 2172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.36Molecular Weight (Monoisotopic): 316.1099AlogP: 4.52#Rotatable Bonds: 4
Polar Surface Area: 57.53Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.80CX Basic pKa: CX LogP: 4.95CX LogD: 4.80
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.42Np Likeness Score: 0.00

References

1. Mittal S, Durani S, Kapil RS..  (1985)  Structure-activity relationship of estrogens: receptor affinity and estrogen antagonist activity of certain (E)- and (Z)-1,2,3-triaryl-2-propen-1-ones.,  28  (4): [PMID:3981542] [10.1021/jm00382a019]

Source